News

AroCell TK 210 ELISA can now be used on automated platforms

Oct 28, 2020

Quantification of Thymidine Kinase 1 in serum with AroCell TK 210 ELISA is now validated for use on an open automation platform for ELISA. This enhances the application and use of the assay.

We have now validated AroCell TK 210 ELISA for use on an automation platform, the Crocodile 5-in-1 ELISA mini workstation. This confirms that our product can both be used in manual operation as well as in automated operation mode. AroCell TK 210 ELISA shows similar high performance in terms of precision and sensitivity when used in this automated system as when run in manual mode, providing maximum flexibility for our customers.

Using AroCell TK 210 ELISA on an automation platform makes it easier than ever to measure levels of Thymidine kinase 1 (TK1) in blood samples (serum or Lithium-heparin plasma) for clinical use or in cell culture and xenografts models during drug development. AroCell TK 210 ELISA measures the concentration of TK1 by immunoassay and detects both active and inactive TK1, does not cross-react with TK2, or with non-human TK1.

Read more about AroCell TK 210 ELISA

Gustav Sten appointed CEO of IDL Diagnostics

IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the position on May 28, immediately following the Annual General Meeting, succeeding Anders Hultman.  Gustav Sten...

read more

Healthcare day 2026

On April 14, IDL participated at Redeye Healthcare Day. CEO Anders Hultman presented the company and shared more about its strategy, current and future markets, and our joint venture with concile. Watch the presentation here

read more